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Abstract. Automatically segmenting sub-regions of gliomas (necrosis,
edema and enhancing tumor) and accurately predicting overall survival
(OS) time from multimodal MRI sequences have important clinical sig-
nificance in diagnosis, prognosis and treatment of gliomas. However, due
to the high degree variations of heterogeneous appearance and individ-
ual physical state, the segmentation of sub-regions and OS prediction are
very challenging. To deal with these challenges, we utilize a 3D dilated
multi-fiber network (DMFNet) with weighted dice loss for brain tumor
segmentation, which incorporates prior volume statistic knowledge and
obtains a balance between small and large objects in MRI scans. For
OS prediction, we propose a DenseNet based 3D neural network with
position encoding convolutional layer (PECL) to extract meaningful fea-
tures from T1 contrast MRI, T2 MRI and previously segmented sub-
regions. Both labeled data and unlabeled data are utilized to prevent
over-fitting for semi-supervised learning. Those learned deep features
along with handcrafted features (such as ages, volume of tumor) and
position encoding segmentation features are fed to a Gradient Boosting
Decision Tree (GBDT) to predict a specific OS day.
1 Introduction
The annual incidence of primary brain tumors is increasing and poses a sig-
nificant burden on public health [7]. Glial cells comprise approximately half of
the total volume of the brain with a glial cell-to-neuron ratio of 1:1 [5]. They
are principally responsible for maintaining homeostasis, providing support and
protecting neurons. Gliomas are the most common primary brain tumors in hu-
mans and originate from glial cells, accounting for 35% to 60% of all intracranial
tumors [7]. The age-standardized incidence rate of gliomas is 4.7 per 100000
person-years and in clinical practice the diagnosis of such tumors requires neu-
rosurgery to obtain a tissue biopsy, which entails considerable risks for patients.
Moreover, according to the World Health Organisation (WHO), gliomas can be
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histologically classified to into four grades, with each resulting in distinctly dif-
ferent durations of overall survival (OS). Although high-grade gliomas (HGG),
i.e. WHO grade III or IV, are considered more aggressive, there is a growing body
of evidence that such a histopathological classification is inadequate to prognos-
ticate OS due to the nuanced variations in molecular profile from one tumor to
the next [6]. By incorporating the glioma pathological diagnosis data, segment-
ing tumor sub-regions exhibited by magnetic resonance imaging (MRI) has been
known to provide additional quantitative information for OS prediction. How-
ever, the process of manual image segmentation is highly time-consuming, often
requires experienced neuro-radiologists and can be subject to inter-observer vari-
ations. To address these issues, developing an automated accurate segmentation
tool that can reliably detect OS-relevant imaging biomarkers is urgently needed.
Gliomas, especially HGGs, often possess intratumoral heterogeneity that
could represent different MRI signal intensity profiles across multi-modality
imaging sequences [12]. Over the last decade, a number of scholars have pro-
posed algorithms to automatically segment these glioma sub-regions in order to
determine an accurate preoperative prognosis with varying degrees of success
[9,10,13,16,18]. Promising progress has been made using traditional machine
learning methods [16,18], which calculated low-level handcrafted, radiological
features to describe images and trained a classifier or a regression for tumor seg-
mentation and OS prediction. These handcrafted features were usually defined by
experienced neuro-radiologists founded on prior knowledge of the exact histolog-
ical diagnosis of the glioma and could have been a potential source of bias. This
simple, straight-forward feature analysis approach potentially also disregarded a
great deal of useful information embedded within the MR images, prohibiting the
full effective utilization of sub-region segmentation for OS prediction. Recently,
deep learning methods have demonstrated superior image processing capabili-
ties that have been proven to effectively overcome these limitations [9,10,11,13].
Instead of defining handcrafted features, Convolutional Neural Network (CNN)
methods jointly trains feature extractor and classifier to adaptively derive high-
yield information and enhance model performance [11]. Inspired by the supe-
rior outcomes of this methodology, researchers are increasingly applying CNN
for brain tumor segmentation and patient OS prediction [9,10,13]. Nie et al.
[13] adopted a VGG-based network to automatically extract high-yield features
from gadolinium contrast-enhanced T1 (T1ce) and diffusion tensor imaging se-
quences, and then utilized the extracted features together with tumor volume
data to train a support vector machine for final OS prediction. Kao et al. [10]
incorporated location information from a brain parcellation atlas to obtain ac-
curate glioma segmentation results. Kao et al. [10] also analyzed connectome
tractography information to identify potentially tumor-induced damaged brain
regions and demonstrated that incorporation of this feature dataset resulted in
superior OS prediction than including customary age, volumetric, spatial and
morphological features alone.
Despite the relatively good performance of automatic tumor segmentation,
the results of OS prediction are far from satisfactory [4,12]. For example, the
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patient OS prediction model of the first-ranking team [9] of the Brain Tumor
Segmentation (BraTS) 2018 challenge, an international competition with open-
source MRI Digital Images in Communications in Medicine (DICOM) data orga-
nized by the School of Medicine of the University of Pennsylvania, only resulted
in a accuracy of 0.62 [4]. Two factors may have resulted in the limited predictive
capacity of previous deep learning methodologies. First, [10] was the first effort
to incorporate tumor location-based information in the CNN for brain tumor
segmentation. However, such location data, which is crucial for OS prediction,
has not been considered to predict OS. Secondly, pre-existing algorithms for OS
prediction were usually based on supervised CNN models. However, the limited
available number of datasets, led to considerable over-fitting problems [9,10,13].
In contrast, unlabeled MRI DICOM data are readily accessible in the clinical
setting. Therefore, making adequate use of such data during the training process
could be a promising strategy to improve OS prediction.
In this paper, we present a 3D dilated multi-fiber network (DMFNet) trained
with weighted dice loss to segment glioma sub-regions from MRI scans. Then
these predicted segmentation results are combined with T1 contrast and T2 MRI
together as inputs for the proposed PECL-DenseNet to extract high-level and
meaningful features that is trained with unlabeled as well as labeled data. In
addition, we combine the extracted deep features from PECL- DenseNet with
handcrafted features (age, tumor volume, volume ratio, surface area, surface
area to volume ratio, location of the tumor’s epicenter, its corresponding brain
parcellation, relevant location of the tumor epicenter to the brain epicenter and
resection status) and position encoding segmentation features to train the Gra-
dient Boosted Decision Tree (GBDT) regression for patient OS prediction.
2 Methodology
2.1 Dataset
The Brain Tumor Segmentation (BraTS) 2019 dataset [1,2,3,4,12] provides 335
training subjects, 125 validation subjects and 167 testing ones, each with four
MRI modality sequences (T1, T1ce, T2 and FLAIR). All the training data have
corresponding pixel-level annotations, including necrosis and non-enhancing tu-
mor, edema, and enhancing tumor sub-regions. Partial training data have corre-
sponding subject-level annotations, indicating the OS duration and the resection
status, respectively. In particular, only HGG patients with gross total resection
(GTR) were evaluated, since resection status is the only consistent modifiable
treatment predictor for OS, and only 101 (30%) training subjects are eligible.
There remaining 109 brain tumor training subjects do not undergo GTR have
OS data and 49 subjects miss OS labels. 29 validation subjects and 107 testing
ones have complete subject-level annotations.
2.2 Brain Tumor Segmentation
A major difficulty with the existing BraTS segmentation challenge is the high
computational cost required, since each subject has four modality MRI scans. To
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Fig. 1: Illustration of DMFNet framework for brain tumor segmentation.
tackle this dilemma, our segmentation model is primarily based on DMFNet [8],
which can significantly reduce the computational cost of 3D networks by an order
of magnitude. It slices a complex neural network into an ensemble of lightweight
networks or fibers, and further incorporates multiplexer modules to facilitate
information flow between fibers. To enlarge the respective field and to capture
the multi-scale 3D spatial correlations, DMFNet adds dilated convolution to
multiplexer modules.
The accuracy of contrast-enhancing tumor segmentation is usually the worst,
compared with peri-tumoral edema and intratumoral necrosis regions, since tu-
mor tissue enhancement often constitutes the smallest volume of the entire tu-
mor. Therefore, we introduce prior volume knowledge to traditional dice loss to
resolve this imbalanced class problem, namely by weighted dice loss. In partic-
ular, we apply the reciprocal of each tumor volume as our dice weight, given as
0.38, 0.15, 0.47 for necrosis, edema and enhancing tumor, respectively.
2.3 Overall Survival Prediction
Features extracted from deep CNN, handcrafted features and position encoding
segmentation features are incorporated for the OS prediction. The geometry and
location of tumor are crucial for the OS prediction [14]. Therefore, we propose a
PECL-DenseNet with considering the location information to extract meaningful
features and make adequate use of unlabeled data to prevent over-fitting. With
the calculated segmentation result, we define 36 handcrafted features that in-
volves geometry and location information for accurate OS prediction. Moreover,
we apply the pooling operator to predicted segmentation to accurately obtain
the tumor location information. GBDT regression is performed to fit with nor-
malized features of 210 training data that is with OS labeling. The source code
for extracting the handcrafted features and implementing GBDT regression is
available at https://github.com/Guo-Xiaoqing/BraTS_OS.
PECL-DenseNet From T1ce, T2 sequence MRI images and the predicted sub-
region segmentation from DMFNet, deep features are extracted by alternate-
cascaded 3D dense blocks and transition layers. The dense connectivities in dense
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Fig. 2: Illustration of the proposed PECL-DenseNet for OS prediction. T1 con-
trast, T2 MRI images and the predicted sub-regions segmentation from DMFNet
are concatenated as the input of the PECL-DenseNet. Deep features extracted
from the PECL-DenseNet are then combined with resection status to make a
five-classes prediction.
Fig. 3: Comparison of 3D convolutional layer and the proposed PECL.
blocks can combine information from different convolutional layers, therefore
encourage feature reuse and ensure maximum information flow between layers.
Specifically, our proposed framework includes four dense blocks as shown in Fig.
2. Each block is comprised of 7 densely connected layers, and every layer consists
of a batch normalization, a ReLU, and the proposed PECL module. Then the
deep features are concatenated with the resection status to derive a five-class
OS prediction classification. Specifically, we utilize a digit to represent resection
status, given as GTR (2), STR (1) and NA (0). The dimension of extracted
image features are reduced to 50 by principal components analysis for further
processing.
We propose a position encoding convolutional layer (PECL) to incorporate
location knowledge for OS prediction. Due to the translation invariance of con-
volution and global average pooling operator, the extracted deep feature vector
usually ignores the spatial information. However, the tumor location is essential
for the diagnosis and prognosis of gliomas, especially for HGG. In this regard, we
extend the conventional 3D convolutional layer to PECL by incorporating the
position information as in Fig. 3. In contrast from the standard convolutional
layer, PECL introduces three extra channels (x, y, z) to derive a 3D Cartesian
coordinate. The introduced channels are individually normalized by dividing
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their maximum value. Then input feature maps are concatenated with these
additional channels for further processing.
To make adequate use of the limited available labeled data and additional un-
labeled data in our hand, we develop an effective loss function for semi-supervised
learning. Assuming the training set is D consisting of N samples. Denoting
L = {(xi, yi)}Li=1 is labeled dataset and U = {xi}Ni=L+1 is unlabeled dataset. We
aim to learn an OS prediction network parameterized by Θ through optimizing
the following loss function:
L =
1
N
N∑
i=1
(α · (n− 1) ‖zi − cyi‖∑n
j 6=yi ‖zi − cj‖
x∈L
−β · yi log pi
x∈L
−γ · pi log pi
x∈U
), (1)
where pi =
eW
>zi+b∑n
j=1 e
W>
j
zi+bj
. Wj is the weight for j
th class in fully connected layer
and bj is bias. zi denotes extracted features of i
th samples and cj is the j
th class
feature centroid. N and n represent batch size and number of classes. α, β, γ are
set as 0.5, 1 and 0.1, respectively. The first term is inspired by [17] and aimed
to enforce the extracted features to approximate their corresponding feature
centroid and to distance away from other centroids. The accumulative feature
centroids are updated by formulation: ct+1j = c
t
j−0.5 ·
∑N
i=1 δ(j=yi)·(cj−xj)
1+
∑N
i=1 δ(j=yi)
, where
t denotes sequential iterations. δ(·) = 1 if condition is satisfied, and δ(·) = 0 if
not. The second term is softmax cross entropy loss for labeled data, and the
third one is an information entropy loss for unlabeled data.
handcrafted feature We define 36 handcrafted features that involves non-
image features and image features. Non-image features includes age and resec-
tion status. In particularly, a two dimensional feature vector is used to repre-
sent resection status, given as GTR (1, 0), STR (0, 1) and NA (0, 0). With
the calculated segmentation from DMFNet, we calculate 34 image features in-
cluding volume (Vwhole, Vnecrosis, Vedema, Venhancing), volume ratio (
Vwhole
Vbrain
,
Vnecrosis
Vbrain
, VedemaVbrain ,
Venhancing
Vbrain
, VnecrosisVenhancing ,
Vedema
Venhancing
, VnecrosisVedema ), surface area (Swhole,
Snecrosis, Sedema, Senhancing), surface area to volume ratio (
Swhole
Vwhole
, SnecrosisVnecrosis ,
Sedema
Vedema
,
Senhancing
Venhancing
), position of the whole tumor epicenter (3 coordinates and its
corresponding brain parcellation), position of the enhancing tumor epicenter (3
coordinates and its corresponding brain parcellation), relevant location of the
whole tumor epicenter to brain epicenter (3 coordinates) and relevant location
of the enhancing tumor epicenter to brain epicenter (3 coordinates). Note that
V and S indicate volume and surface area. whole, necrosis, edema, enhancing
and brain denote the entire tumor, necrosis and non-enhancing tumor, edema,
enhancing tumor and the entire brain, respectively. To obtain the brain parcella-
tion for tumor epicenter location, we register all the data to LPBA40 atlas [15],
and 56 different brain parcellations are delineated.
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Position encoding segmentation To reserve the tumor location information,
we apply a pooling operator to the predicted segmentation, where the kernel of
the pooling operator is 5× 12× 12 and the resolution of predicted segmentation
is 155× 240× 240. Thus, a 12400-dimensional feature vector is obtained.
3 Experiments and Results
3.1 Experiment Setup
In the brain tumor segmentation experiment, we trained the DMFNet with all
the 335 training subjects and evaluated on 125 validation subject data and 167
testing data. We used a batch size of six and trained the DMFNet on two parallel
Nvidia GeForce 1080Ti GPUs for 300 epochs. The initial learning rate was set
as 0.001. During the training phase, we randomly cropped the data into 128 ×
128× 128 for training data augmentation. In the testing phase, we utilized zero
padding to make the resolution of input MRI data 240× 240× 160.
In the OS prediction experiment, we made subjects with OS labels (101 +
109 = 210 subjects) as labeled data, and regarded the remaining 49 subjects
without OS labels and 96 validation subjects as unlabeled data for the 3D
PECL-DenseNet training in a semi-supervised strategy. Results of OS predic-
tion were evaluated on 29 validation subjects and 107 testing ones. During 3D
PECL-DenseNet training, the initialized learning rate was set to 0.1, and was
dropped by 0.1 at 150 and 250 epochs, respectively. All training steps for labeled
data and unlabeled data both use batch size of four. Both handcrafted features
and location encoding segmentation features are extracted from 210 training
subjects, 29 validation subjects and 107 testing ones, which are then combined
with deep features extracted from PECL-DenseNet to feed into the GBDT for
training and testing, respectively.
3.2 Results
Brain Tumor Segmentation For brain tumor segmentation, we first con-
ducted five-fold cross-validation evaluation on the training set, and our DMFNet
achieved average dice scores of 80.12%, 90.62% and 84.54% for enhancing tumor
(ET), the whole tumor (WT) and the tumor core (TC), respectively. The segmen-
tation results are shown in Fig. 4, and our results match well with ground truth.
Besides, 125 validation cases were evaluated after submitting to the CBICA’s
Image Processing Portal, achieving average dice scores of 76.88%, 89.38% and
81.56% for ET, WT and TC, respectively. The 3rd row in Table 1 shows the per-
formance metrics that the segmentation network achieved on the testing data. It
obtains average dice scores of 78.99%, 86.71% and 82.09% for ET, WT and TC,
respectively. We also visualized the segmentation results of DMFNet, as shown
in Fig. 5.
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Fig. 4: Prediction of DMFNet for BraTS 2019 cross-validation on training data.
(a) MRI (T1ce), (b) predicted segmentation (c) ground truth.
Fig. 5: Prediction of DMFNet for BraTS 2019 validation and testing data. (a)
Validation data; (b) predicted segmentation on (a); (c) testing data; (d) predicted
segmentation on (c).
Overall Survival Prediction We extracted different features to solve OS pre-
diction problems as follows:
(a) Features extracted from PECL-DenseNet
(b) handcrafted features
(c) Position encoding segmentation features
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Table 1: Dice and Hausdorff for BraTS 2019 validation and testing dataset.
Dataset Dice ET Dice WT Dice TC Hausdorff ET Hausdorff WT Hausdorff TC
Validation 76.88% 89.38% 81.56% 4.50841 5.03648 6.58191
Testing 78.99% 86.71% 82.09% 20.24 12.45 26.99
Table 2: 36 handcrafted VS 18 handcrafted.
Method Accuracy MSE medianSE stdSE SpearmanR
36 handcrafted 0.31 152597.065 76777.495 192410.851 -0.091
18 handcrafted 0.448 142485.235 64070.727 192720.964 0.061
Firstly, we trained GBDT regression with 36 handcrafted features. Subse-
quently, 18 important features were selected by their regression weight and fed
into GBDT regression model for training. A comparison of the results obtained
from training with 36 and 18 handcrafted features are shown in Table 2. It is
clear that feature selection improves the performance of OS prediction.
Moreover, we arranged and combined features (a), (b), (c) to train the GBDT
regression model, and the corresponding results on validation data were shown in
Table 3. It is obvious that handcrafted features is of great importance compared
with the deep features (a) and position encoding features (c) (2nd to 4th rows).
Selecting and combining these three features groups, it is observed that incor-
porating both handcrafted features and location encoding segmentation data
achieved the highest accuracy of 0.586 (Method 6). We then saved the parame-
ters obtained from the regression model that yielded the best result and applied
it on testing data (Table 4). We achieved an accuracy of 0.523 for OS time
prediction.
4 Conclusion
In this paper, we utilize DMFNet with weighted dice loss for brain tumor segmen-
tation, which significantly reduces the computation cost and obtains a balance
between small and large objects from MRI scans. Segmentations predicted from
DMFNet are further utilized to provide explicit tumor information for patient
OS prediction. As for OS prediction, GBDT regression is implemented by com-
bining of deep features derived from the proposed PECL-DenseNet, handcrafted
features and position encoding segmentation features. Specifically, we propose a
PECL-DenseNet to extract meaningful features, which makes adequate use of
unlabeled data and to prevent over-fitting issues. Besides, several clinical fea-
tures are defined and combined with the deep features from PECL-DEnseNet
to train GBDT regression for OS days prediction. Although our methods re-
veals promising performances for both the brain tumor segmentation and OS
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Table 3: Validation results of OS prediction with different methods.
Method a b c Accuracy MSE medianSE stdSE SpearmanR
method 1
√
0.379 431949.975 270585.384 488132.042 -0.347
method 2
√
0.448 142485.235 64070.727 192720.964 0.061
method 3
√
0.379 105019.348 47771.914 139093.436 0.07
method 4
√ √
0.483 118374.49 68989.292 132897.288 0.238
method 5
√ √
0.448 120356.082 52497.44 186701.876 0.012
method 6
√ √
0.586 104985.694 86581.049 117638.724 0.218
method 7
√ √ √
0.517 200169.575 51368.509 309567.261 0.142
Table 4: Testing results of OS prediction with the method 6.
Accuracy MSE medianSE stdSE SpearmanR
0.523 407196.811 55938.713 1189657.961 0.281
prediction tasks, we believe that the performance will be further improved by
integrating more MRI modality data and brain tumor molecular information.
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